Rheumnow

Topic Podcasts - PsA Part2

Informações:

Synopsis

ACR 2022 Appraisal, Praise & Critique (11.18.2022) Best of ACR Day Two in PSA Efficacy and Safety Results from BE OPTIMAL in PsA JAK inhibitors in rheumatic diseases Oligoarticular PsA: FOREMOST Study Opioid use in PsA and SpA PET CT Imaging to Define Risk of Progression from PSO to PsA PsA and SPA: Cyclers, Switchers, Who is the Winner? Switch vs Cycle in PsA Women vs. Men: Response to Treatment in Seronegative Arthritis